1.59
1.85%
-0.03
Entera Bio Ltd (ENTX) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
5.04%
2.062
|
1.963 | 2.386 | 2.33 | 2.212 |
Operating Income/Loss |
5.04%
-2.062
|
-1.963 | -2.386 | -2.33 | -2.212 |
Nonoperating Income/Loss |
240.62%
0.045
|
-0.032 | 0.036 | 0.005 | 0.022 |
Income/Loss From Continuing Operations Before Tax |
1.10%
-2.017
|
-1.995 | -2.35 | -2.325 | -2.19 |
Income/Loss From Continuing Operations After Tax |
1.10%
-2.017
|
-1.995 | -2.379 | -2.325 | -2.19 |
Net Income/Loss
|
1.10%
-2.017
|
-1.995 | -2.379 | -2.325 | -2.19 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
18,674%
36.74
|
0.1957 | 28.81 | 28.81 | 28.81 |
Diluted Average Shares |
18,674%
36.74
|
0.1957 | 28.81 | 28.81 | 28.81 |
Basic Earnings Per Share |
28.57%
0.05
|
0.07 | 0.08 | 0.08 | 0.08 |
Diluted Earnings Per Share |
28.57%
0.05
|
0.07 | 0.08 | 0.08 | 0.08 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):